Table 3.
Effect of prehabilitation in patients with modifiable risk factors in 126 patients
| n = 126 | I Before | II After | p |
|---|---|---|---|
| Patient factors | |||
| Smoking (n,%) | 32 (25) | 16 (13) | 0.0103 |
| BMI (median, IQR) | 30 (27–33) | 29 (27–31) | < 0.001 |
| BMI > 30 (n,%) | 65 (52) | 48 (38) | 0.0312 |
| BMI > 35 (n,%) | 14 (11) | 7 (6) | 0.1106 |
| Diabetes (n,%) | 19 (15) | 19 (15) | 1.000 |
| HbA1c (median, IQR) | 48 (34–54) | 47.5 (42–55) | 0.065 |
| HbA1c > 65 (n,%) | 3 (1) | 1 (1) | 0.3134 |
| Immunosuppressives (n,%)* | 10 (8) | 5 (4) | 0.1831 |
| MET score < 4 (n,%) | 12 (10) | 5 (4) | 0.0787 |
*Patients who did not alter their regular immunosuppressives schedule were considered still using immunosuppressives
Statistically significant values are shown in bold